TetraLogic Pharmaceuticals Corporation
TLOG · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $27 | $20 | $10 | $12 |
| G&A Expenses | $11 | $11 | $8 | $4 |
| SG&A Expenses | $11 | $11 | $8 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $39 | $31 | $18 | $16 |
| Operating Income | -$45 | -$34 | -$18 | -$16 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$11 | -$5 | -$2 | -$0 |
| Pre-Tax Income | -$50 | -$36 | -$20 | -$16 |
| Tax Expense | $6 | $3 | $3 | $0 |
| Net Income | -$56 | -$39 | -$23 | -$16 |
| % Margin | – | – | – | – |
| EPS | -2.37 | -1.76 | -9.9 | -16.78 |
| % Growth | -34.7% | 82.2% | 41% | – |
| EPS Diluted | -2.36 | -1.76 | -9.9 | -16.78 |
| Weighted Avg Shares Out | 24 | 22 | 2 | 1 |
| Weighted Avg Shares Out Dil | 24 | 22 | 2 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $3 | $3 | $0 |
| Depreciation & Amortization | $7 | $3 | $0 | $0 |
| EBITDA | -$43 | -$32 | -$17 | -$16 |
| % Margin | – | – | – | – |